National consensus of management patients with abnormal uterine bleeding by association of gynecologist and endocrinologist of Ukraine

В. М. Запорожан, Т. Ф. Татарчук, А. Бер, Н. В. Авраменко, О. В. Булавенко, Ю. П. Вдовиченко, І. Ю. Ганжий, Н. І. Геник, О. В. Грищенко, А. М. Громова, О. В. Демченко, З. М. Дубоссарська, О. О. Єфименко, Н. Я. Жилка, В. П. Квашенко, Н. В. Косей, Л. Б. Маркін, В. І. Медведь, Н. Ю. Педаченко, Н. М. Рожковська, Г. Б. Семеніна

Abstract


Current classification of abnormal uterine bleeding, review of diagnostic methods and treatment strategies of the condition are presented in the article. Moreover, evidence based algorithms of the diagnosis and treatment of this condition considering the features of the health care system in Ukraine are given


Keywords


abnormal uterine bleeding; PA LM-COE IN classification; hormone therapy; nonhormonal therapy; surgical treatment

References


Munro, M.G. Abnormal uterine bleeding. Cambridge: Cambridge University Press (2010).

National Collaborating Centre for Women’s and Children’s Health; National Institute for Health and Care Excellence. NICE guideline CG44: heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists (2007).

Fraser, I.S., Warner, P., Marantos, P.A. “Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume.” Obstet Gynecol, 98(5 Pt 1) (2001): 806–814.

“Management of acute abnormal uterine bleeding in non-pregnant women“. Committee Opinion № 557. American College of Obstetricians and Gynecologists. Obstet Gynecol, 121(2013): 891–896.

Breymann, C. J. Perinat Med, 38(2010).

Lethaby, A., Augwood, C., Duckitt, K., Farquhar, C. “Nonsteroidal anti- inflammatory drugs for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2007): CD000400.

Hall, P., MacLachlan, N., Thorn, N., Nudd, M.W.E., Taylor, G.G., Garrioch, D.B. “Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid.” BJOG, 94(1987): 554–558.

Gleeson, N., Buggy, F., Sheppard, B.L. “The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.” Acta Obstet Gynecol Scand, 73(1994): 274–277.

Lethaby, A., Farhuhar, C., Cooke, I. “Antifibrinolytics for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2000): CD000249.

Ong, Y.L., Hull, D.R., Mayne, E.E. “Menorrhagia in von Willebrand disease successfully treated with single daily dose tranexamicacid.” Haemophilia, 4(1998): 63–65.

Farquhar, C., Brown, J. “Oral contraceptive pill for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2009):CD000154.

Fraser, I.S., McCarron, G. “Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia.” Aust N Z J Obstet Gynaecol, 31(1991): 66–70.

Nappi, R.E. “Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.” Int J Womens Health, 6(2014): 711–718.

Stewart, F.H., Kaunitz, A.M., Laguardia, K.D. “Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.” Obstet Gynecol, 105(2005): 1389–1396.

Lethaby, A., Irvine, G.A., Cameron, I.T. “Cyclical progestogens for heavy menstrual bleeding.” Cochrane Database Syst Rev, 1(2008):CD001016.

Irvine, G.A., Campbell-Brown, M.B., Lumsden, M.A, Heikkila, A., Walker, J.J., Cameron, I.T. “Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.” BJOG, 105(1998): 592–598.

Marjoribanks, J., Lethaby, A., Farquhar, C. “Surgery versus medical therapy for heavy menstrual bleeding.” Cochrane Database Syst Rev, 2(2006): CD003855.


GOST Style Citations






DOI: http://dx.doi.org/10.18370/2309-4117.2015.21.7-14

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)